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Abstract
Background: Routine influenza surveillance, based on laboratory confirmation of viral infection, often fails to estimate the true
burden of influenza-like illness (ILI) in the community because those with ILI often manage their own symptoms without visiting
a health professional. Internet-based surveillance can complement this traditional surveillance by measuring symptoms and health
behavior of a population with minimal time delay. Flusurvey, the UK’s largest crowd-sourced platform for surveillance of
influenza, collects routine data on more than 6000 voluntary participants and offers real-time estimates of ILI circulation. However,
one criticism of this method of surveillance is that it is only able to assess ILI, rather than virologically confirmed influenza.
Objective: We designed a pilot study to see if it was feasible to ask individuals from the Flusurvey platform to perform a
self-swabbing task and to assess whether they were able to collect samples with a suitable viral content to detect an influenza
virus in the laboratory.
Methods: Virological swabbing kits were sent to pilot study participants, who then monitored their ILI symptoms over the
influenza season (2014-2015) through the Flusurvey platform. If they reported ILI, they were asked to undertake self-swabbing
and return the swabs to a Public Health England laboratory for multiplex respiratory virus polymerase chain reaction testing.
Results: A total of 700 swab kits were distributed at the start of the study; from these, 66 participants met the definition for ILI
and were asked to return samples. In all, 51 samples were received in the laboratory, 18 of which tested positive for a viral cause
of ILI (35%).
Conclusions: This demonstrated proof of concept that it is possible to apply self-swabbing for virological laboratory testing to
an online cohort study. This pilot does not have significant numbers to validate whether Flusurvey surveillance accurately reflects
influenza infection in the community, but highlights that the methodology is feasible. Self-swabbing could be expanded to larger
online surveillance activities, such as during the initial stages of a pandemic, to understand community transmission or to better
assess interseasonal activity.
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Introduction
Influenza and influenza-like illness (ILI) cause a considerable
burden of illness in the UK [1]. For most people, influenza is
usually a self-limited disease for which, on average, between
1.5 and 4.9 working days are lost for each episode [2]. The
consequences for high-risk groups (very young, older people,
pregnant women, and those with an underlying health condition)
can be more serious. Public Health England (PHE) estimate that
each winter hundreds of thousands of people see their general
practitioner (GP), tens of thousands are hospitalized, and there
are on average 8000 deaths because of influenza [3-5].
Moreover, it has been estimated in 2011 that an outbreak of
pandemic influenza could reduce the UK gross domestic product
by approximately 1.14% to 1.42% (£14.8-£18.5 billion) [6].
Surveillance is an essential function for monitoring seasonal
and pandemic influenza, delivering epidemiological, virological,
and clinical awareness of the circulating virus and studying
interventions, such as vaccination programs [7]. However,
routine surveillance through medical settings (GPs and
hospitals), based on laboratory confirmation of infection, does
not provide a full picture of the true societal burden of influenza
at any one time due to the fact that individuals suffering from
ILI often do not visit a health care professional, but manage
their symptoms on their own [8,9]. Syndromic surveillance of
ILI is increasingly used as a method for detecting discernible
trends in illness, without laboratory confirmation [10]. For
example, PHE collates data from a range of sources to compile
its weekly national influenza reports, including NHS 111 (a
nonemergency health advice phone line), the Royal College of
General Practitioners’ (RCGP) Weekly Returns Service
(GP-based sentinel surveillance), Medical Offices of Schools
Association, community telephone surveys, and online disease
surveillance platforms such as Flusurvey [11].
Flusurvey, the UK’s largest crowd-sourced platform for
surveillance of influenza, collects routine data on more than
6000 voluntary participants [12]. On registration, a baseline
epidemiological questionnaire is carried out, asking about
individuals’ age, gender, location (first part of postcode),
household composition, influenza vaccine status, and preexisting
health conditions. Although Flusurvey participants are not
representative of the UK population, adjustments are made
through modeling processes to allow for broader calculations
to be made at the population level. Subsequently, participants
are emailed each week to complete a symptoms survey.
Participants select recent symptoms from a list including
respiratory and gastrointestinal concerns, and provide
information relating to onset and duration of symptoms and
health-seeking behavior, as well as rating how they are feeling
overall on a scale of 1 (very unwell) to 100 (in excellent health)
[13]. Accordingly, by gathering these datasets, it is possible to
estimate, with minimum delay, the incidence of ILI among
Flusurvey participants, which has been previously shown to
correlate with the incidence measured by sentinel-based
surveillance at PHE [14].
Internet surveillance can complement traditional surveillance
by measuring symptoms among a population with minimal time
delay [15]. When this is done continually, it can improve the
quality of the incidence data and help to inform policy decisions
during routine seasonal influenza and pandemics [15]. The use
of internet-based disease surveillance has increased rapidly in
the past decade, including online ILI syndromic survey systems,
such as the Europe-wide Influenzanet (of which Flusurvey is a
member, working in synergy with other European platforms
sharing data collection modality and results) [16], FluNearYou
in the United States [17], and Australia’s Flutracking [18].
Estimates of the relative incidence of influenza have also been
inferred from search engine query data [19], detecting news
reports from news sites aggregators [20], social media platforms
such as Twitter [21], Wikipedia access logs [22], restaurant
reservation and review logs [23], nonprescription pharmacy
sales [24], and prediction markets [25]. Moreover, online
crowd-sourced surveillance platforms have been similarly
developed for other health conditions, including malaria [26],
food-borne illness [27], and tick-borne diseases such as Lyme
disease [28].
One criticism of online surveillance for influenza (and other
syndromic surveillance mechanisms) is that because data are
based on self-reporting of symptoms, the results collected are
only representative of ILI, rather than virologically confirmed
influenza [29]. Although previous years of ILI incidence from
Flusurvey corresponded to RCGP influenza data, suggesting
that Flusurvey does detect outbreaks of influenza, this has not
been confirmed. Virological confirmation studies are required
to assess how the measured ILI rates compare with the actual
circulation of influenza in the population. Previously, two studies
have sought to do this: one undertook a virological self-sampling
from those calling the UK national telephone health helpline
(NHS Direct) [30,31] and one completed virological
self-sampling of GoViral participants in Massachusetts [32].
Similar self-testing or self-sampling studies have been
undertaken for HIV/AIDS [33-35] and chlamydia, where the
online cohort approach has been combined with a complete
eSexual Health Clinic [36].
We designed a pilot study to assess whether it was feasible to
detect laboratory-confirmed influenza from an online cohort.
We monitored ILI through the Flusurvey platform, asking those
reporting ILI to undertake a nasal swab for laboratory
assessment of whether they were actually infected with an
influenza virus, another respiratory virus, or unknown etiology
(including viruses not tested for). This pilot study will help to
assess the validity of online platforms for ILI surveillance and
to confirm if the syndromic cohort surveillance approach is able
to detect influenza infection. Moreover, it will additionally serve
as a proof-of-concept study, showing that self-testing in the
community can be successfully added to internet-based
surveillance of ILI.
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Methods
We recruited unvaccinated volunteer participants by including
“Would you be interested in taking part in a virological
self-swabbing study?” on Flusurvey’s regular baseline
recruitment survey [12]. Only unvaccinated participants were
selected to offer increased chances of testing positive for
influenza. Recruitment into the pilot was open from November
17, 2014 to December 17, 2014, with 1615 potential participants
volunteering. As a feasibility study, limited by financial
constraints, we sought to generate 100 swabs for testing. Based
on experience from Flusurvey and the Flu Watch study [9], we
estimated that approximately 48% of participants would
experience a respiratory illness during periods of influenza
circulation, 43% (3/7) of those would have an onset on the day
or within the 2 days of reporting the illness (important for a
high viral load to facilitate laboratory testing), and that 70% of
those requested to return a swab would do so. Given these
parameters a total of 700 individuals were recruited to take part
in the self-swabbing pilot. Accordingly, we purposefully
sampled 700 of 1615 eligible participants to include high-risk
groups for influenza infection, including all those younger than
18 years and older than 65 years who volunteered or were
volunteered by parents [37,38]. Random sampling of those aged
between 18 and 64 years was then undertaken to reach a total
of 700 participants. We sent these 700 participants a cover letter,
an information sheet on the project, the virological swabbing
kit, and sample transport materials (Multimedia Appendix 1).
The virological swab kit contained a regular tip flocked swab
plus 1 mL Universal Transport Medium (Sterilab, North
Yorkshire, UK). For transportation of the sample to the
laboratory, the pack contained a round mailing container
(126 × 30 mm) with liner, a neutral screw cap for the mailing
container, and a mailing box packaging system for containers
up to 30 mm (Sarstedt, Numbrecht, Germany) to meet Category
B UN3373 posting standards for viral materials. Also included
were instructions for undertaking the swabbing (Multimedia
Appendix 2), a link to video instructions [12], and identification
labels for the samples (Multimedia Appendix 3). Participants
were asked to store it safely until instructed to self-swab.
Informed consent was obtained from pilot study participants
when they selected that that they were willing to take part in
the study online.
Participants were asked to report their symptoms online on a
weekly basis. If their symptoms met the European Centre on
Disease Prevention and Control definition of ILI, which is
sudden onset of symptoms and at least one of four systemic
symptoms (fever or feverishness, malaise, headache, myalgia)
and at least one of three respiratory symptoms (cough, sore
throat, shortness of breath) [39], and if the reported date of onset
of symptoms was within 4 days of notification (to ensure
virological testing during the acute phase of infection with
expected higher viral loads [40]), then participants were asked
to self-swab. Due to low circulation of influenza during the time
period of the pilot study [14], the swabbing criteria were
expanded on March 16, 2015, to include acute respiratory
infection (ARI). (This comprises the sudden onset of symptoms
and at least one of the following four respiratory symptoms:
cough, sore throat, shortness of breath, and coryza [39].)
Nasal swabbing was chosen because it has been shown to be
effective for influenza testing by patients [41] and offers a
greater viral load than saliva collection [32]. Although
nasopharyngeal swabbing may yield a slightly greater viral load
for confirmation with polymerase chain reaction (PCR) tests
[42], we believed it would be difficult to self-administer
nasopharyngeal swabs of consistent quality and therefore flocked
nasal swabs provided a suitable alternative [43]. Participants
were provided with both written and video instructions as to
how to administer the self-swab (Multimedia Appendix 2).
Participants were asked to send their samples (Multimedia
Appendix 2) to the PHE Laboratory, Bristol, for respiratory
virus PCR testing. The samples were assayed using PHE Bristol
in-house–validated PCR panels including targets for common
respiratory infections, including influenza A, influenza B,
respiratory syncytial virus (A and B) human metapneumovirus,
parainfluenza virus (1, 2, and 3), adenovirus, and rhinovirus.
This assay was chosen based on its confidence in detecting
circulating strains of influenza. The PHE Laboratory used a
generic influenza A assay that is assessed in silico against
common circulating strains (primer and probe matching) and
then tested in practice using a proficiency panel constructed by
the respiratory virus unit from PHE, plus other external quality
assurance schemes. Results were returned to researchers at the
London School of Hygiene and Tropical Medicine and sent to
participants via email. As this was a pilot research study, rather
than a clinical test, participants were informed before
self-sampling that their results would not be available in real
time.
It was important to ascertain whether samples with negative
results through the PCR multiplex testing were truly negative
or whether the test had not been administered properly,
providing a false negative. Second-stage testing was undertaken
at London Centre for Nanotechnology, University College
London. These samples were quantified for human nuclear and
mitochondrial DNA by TaqMan PCR for mammalian
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) DNA in
the swab samples [44]. Positive controls for the reaction were
either HeLa cell DNA (NEB, Hitchin, UK) or human placental
DNA (Sigma, Dorset, UK). Cycling conditions were 95°C for
15 seconds and annealing/extension at 60°C for 1 minute after
an initial denaturation of 10 minutes.
Finally, we asked those participants to complete a short
evaluation form online to ascertain how easy they found the
process and its viability for future (Multimedia Appendix 4).
Ethics approval for undertaking this study was obtained from
Observational and Interventions Research Ethics Committee at
London School of Hygiene and Tropical Medicine (ref:
5530-03).
Results
Samples were received at PHE Laboratory, Bristol, from January
1, 2015 to April 7, 2015. In total, 66 participants from the pilot
group (of the 100 originally estimated based on sample size
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calculations) met the symptom and timing of onset criteria and
were asked to self-swab. A total of 51 swab samples (77%) were
received at PHE Laboratory. An additional three samples were
received, although they were not requested, and therefore they
were not included in the analysis. Multiplex PCR testing results
are presented in Table 1 and Multimedia Appendix 5.
The second-stage testing for the presence of human DNA
produced the results presented in Table 2 and Multimedia
Appendix 6.
These findings show all samples contained human DNA and
are consistent with the correct use of the swab, corroborating
earlier successful experiences of self-swabbing in a home setting
[9,32,41]. This validated the feasibility and the process used as
well as the respiratory virus detection results.
Reflecting similar demographic trends from the broader
Flusurvey project [45], including from the 2014-2015 cohort
from which these participants were selected [46], the swabs
received at the laboratory for virological testing were not
representative of the UK population. Of the 51 results received,
36 were received from female participants and 15 were from
male participants. The age of participants ranged from 4 to 91
years with a mean age of 41 (SD 19) years.
As part of the routine information collected by Flusurvey,
participants are asked to score how they were feeling each week
[13]. Over the course of the 2014-2015 influenza season, the
mean reported score for all Flusurvey users (N=6102) was 82.9.
This is self-reported on a scale from 0 to 100. For the 66
self-swab participants, the mean score for the weeks they
reported ILI (or ILI and ARI after March 16, 2015) was 63.9
(SD 23.9). From those who tested positive for ILI, the range of
scores was 30 to 100 and the mean was 72.8 (SD 16.9). Finally,
for those who tested positive for influenza, the range was 60 to
85 and the mean was 72 (SD 9). Although there is a great risk
of overinterpretation with a small sample size, and a risk of bias
by characteristics of people self-swabbing, these results do not
suggest a positive relationship between incidence of ILI and
(self-reported) severity of symptoms through the health score.
Completed evaluation forms were received from 21 participants.
Of these, 20 participants suggested that undertaking the swab
was easy or very easy, although one stated it was “unpleasant.”
In addition, 13 participants indicated that if they were to have
ILI symptoms in the future, they would prefer to undertake a
self-swab at home to diagnose symptoms, five participants
preferred to treat symptoms at home without a swab, and three
participants were undecided about their future use of swabbing
at home. All those who completed the evaluation form found
the written instructions helpful, and 13 participants found the
video instructions useful, with the remaining eight participants
not watching it.
Table 1. Yield of influenza-like illness positive tests from samples tested (N=51) using multiplex quantitative PCR..
Positive tests, n (%)Virus
1Influenza A (H3N2)
4Influenza B
2Human metapneumovirusa
11Rhinovirusa
2Inhibitory samplesb
18 (35)Total viral yield
5 (10)Total influenza yield
aOne sample tested positive for both human metapneumovirus and rhinovirus. We have included both of these infections separately in this table, but
this reflects one dual infection.
bTwo samples contained inhibitory substances that hindered amplification of sample control markers. No conclusions can therefore be drawn from these
samples, positive or negative.
Table 2. Detection of mammalian DNA using Taqman quantitative polymerase chain reaction.
GAPDH level (Cta), mean (SD)Samples, nGroup
28.4 (2.9)20No virus detected
28.7 (2.5)11Virus detected
28.2 (4.7)5Low virus detected
26.1 (3.7)2Inhibitors present
23.7 (1.6)3Not tested for virus
aCt: cycle threshold. A Ct value <40 represents positive detection of human DNA.
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Discussion
This study has shown that, as a proof of concept, it is possible
to successfully apply an at-home self-swabbing methodology
to an internet-based cohort and that this can detect both influenza
and other causes of ILI by collecting viral samples of suitable
quality for PCR multiplex testing. This replicated findings of
similar studies conducted for self-swabbing from an online
cohort through the GoViral Platform in the United States,
through phone-based surveillance via NHS Direct, and in
community self-swabbing through Flu Watch [9,31,32],
extending these to assess feasibility among a crowd-sourced
platform. It was estimated that in the 2014-2015 influenza
season, there were low to moderate levels of influenza activity
with the predominant strain influenza A (H3N2) [14] present
for the majority of the season (the majority were antigenically
similar to the A/Texas/50/2012 H3N2 Northern Hemisphere
strain), and the appearance of influenza B during the last months
of the season (the majority of these belonged to the B/Yamagata
16/88 lineage) [14]. This pilot study did not generate a large
yield of ILI virus-positive results, nor was it powered to, yet
there were similar trends between this pilot and PHE
Laboratory–confirmed cases for the same time period and in
particular from the RCGP sentinel swabbing scheme, to which
this would be most similar for detecting influenza in a
community cohort [14].
Participants found the self-swabbing easy to undertake and
several individuals in the pilot indicated that they would be
interested in using a similar self-swab in the future if they
wanted laboratory confirmation of ILI infection. This was a
research project, therefore testing of the samples was not
undertaken in real time and results were not returned to
participants for a number of weeks, by which time their
symptoms would have likely subsided, meaning that the results
of the virological test would not have affected their behavior.
However, if self-swabbing were to be conducted and results
returned in real time, the results may affect patient behavior,
either through visiting a health professional, taking medication,
or changing their daily routine to limit potential viral spread.
Moreover, virological confirmation of a viral infection may
potentially reduce antibiotic prescription due to misdiagnosis.
Usability of Findings
Yet, we do not wish to suggest that this methodology should
replace the efficient RCGP sentinel swabbing system; our
approach may not be practical for routine influenza surveillance
owing to the cost and logistics of distributing kits. However,
self-swabbing of an internet-based cohort may prove useful for
ad hoc surveys, such as in the emerging stages of a pandemic
to understand community transmission or as a supplementary
tool to otherwise established surveillance mechanisms. Our
study can also contribute to demonstrating the feasibility of both
an online cohort approach to surveillance and self-swabbing at
home for other health conditions, such as sexually transmitted
infections or gastroenteritis for which there might be privacy
reasons for patients seeking to test themselves at home.
Although this pilot study cannot make conclusive remarks about
the validity of online influenza surveillance, it has shown that,
as a proof of concept, it is possible to detect an influenza virus
and other ILI from a cohort of online participants. Accordingly,
this can be replicated at larger scale for greater verification of
online crowd-sourced disease surveillance mechanisms.
Moreover, if a self-swabbing study were to be repeated with a
greater number of participants and samples, from a more
representative demographic sample, it may be possible to build
these into a strong analytical model for estimating the burden
of influenza.
Limitations
Due to delays in procuring the necessary materials, delays in
obtaining ethical approval, postal delays, and closures due to
Christmas, the self-swab kits were not distributed to participants
until the first week of January 2015. Retrospectively, it can be
seen that the peak of the influenza season in the UK during the
2014-2015 season was week 52 (December 22-28, 2014) [14].
As such, the study did not take place during the peak influenza
season in the UK and there were not high levels of influenza
circulating during the pilot period. Accordingly, we did not have
a large sample group of swabs nor did we obtain the predicted
100 swabs. Despite the methodological change to include ARI
on March 16, 2015 [39], this still failed to collect the original
requirement of 100 samples. This trend matched PHE’s
microbiological surveillance for the same time period, with a
similarly low yield of influenza-positive samples [14]. However,
the pilot study did coincide with the later peak of influenza B
[14], and hence detections of influenza B.
If this project were to be undertaken again, swab kits should be
distributed to participants before the start of the influenza season
to mitigate the uncertainty of predicting when the virus may
arrive and/or be at its peak. Alternatively, kits should be sent
out, or be collectable locally, after notification of relevant
symptoms. Although this delay may impact the viral load
collected, it would prove more cost effective in a health care
setting.
The participants who sent samples to the laboratory for testing
were not a representative sample demographically, featuring
predominantly women aged between 18 and 64 years in
Southeast England. This reflects Flusurvey and Influenzanet
participants more generally and does not represent a random
sample of the UK/European populations [47]. Any future
self-swabbing studies carried out on an internet-based cohort
could broaden the demographics of the sample to increase the
study’s applicability. This could include greater recruitment
drives among underrepresented groups or more purposeful
sampling to take the bias of the wider Flusurvey group into
account.
A further limitation was that not all respiratory viruses were
tested for (eg, coronavirus and enterovirus). However, because
this was a proof-of-concept study for Flusurvey, a
crowd-sourcing platform for influenza surveillance, the focus
remained on assessing influenza and other respiratory infections
were considered to be supplementary. This may account for the
individuals who reported symptoms, but whose swabs tested
negative for influenza.
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Conclusion
This pilot study has shown that it is feasible for individuals to
conduct self-swabbing for ILI/ARI in their own home at
relatively low cost. Those selected to participate were able to
successfully collect samples and the biological material gathered
was sufficient for influenza and other viruses to be detected in
the laboratory. This allows us to conclude that, as a proof of
concept, it is possible to use home swabbing for detection of
influenza at the community level. Due to the small sample size,
conclusive statements about how effective the Flusurvey
algorithms may be in comparison to other forms of
community-based surveillance cannot be made, yet it still
validates the conceptual approach used for online symptomatic
surveillance methodology. However, there remain concerns
about the accuracy of such a system and further research would
be needed to repeat a similar experiment with a greater number
of participants to provide a suitable sample size to make any
broader assumptions about the accuracy of online influenza
detection systems.
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